Dual Site-dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Stroke Patients
NCT ID: NCT03486782
Last Updated: 2020-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-05-29
2020-03-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dual Site-dual Channel Non-invasive Brain Stimulation for Motor Function in Stroke Patients
NCT03486769
Effects of rTMS Based on Brain Activation During Language Performance in Stroke Patients With Non-fluent Aphasia
NCT02556385
The Effect of tDCS on Motor Learning and Neural Network in Stroke Patients
NCT04903457
Effects of rTMS Based on Neural Activation in Language Performance in Stroke Patients With Non-fluent Aphasia
NCT02591719
Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.
NCT04432883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dual stimulation
i) anodal stimulation of ipsilesional inferior frontal cortex and cathodal stimulation of contralesional supraorbital area ii) anodal stimulation on ipsilesional dorsolateral prefrontal cortex and cathodal stimulation of contralesional supraorbital area
IFG stimulation
stimulating inferior frontal cortex with transcranial direct current stimulation for 30 minutes
DLPFC stimulation
stimulating dorsolateral prefrontal cortex with transcranial direct current stimulation for 30 minutes
aphasia therapy
aphasia therapy for 30 minutes during transcranial direct current stimulation
Single stimulation 1
i) anodal stimulation of ipsilesional inferior frontal cortex and cathodal stimulation of contralesional inferior frontal cortex
IFG stimulation
stimulating inferior frontal cortex with transcranial direct current stimulation for 30 minutes
aphasia therapy
aphasia therapy for 30 minutes during transcranial direct current stimulation
Single stimulation 2
i) anodal stimulation of ipsilesional inferior frontal cortex and cathodal stimulation of contralesional supraorbital area
IFG stimulation
stimulating inferior frontal cortex with transcranial direct current stimulation for 30 minutes
aphasia therapy
aphasia therapy for 30 minutes during transcranial direct current stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IFG stimulation
stimulating inferior frontal cortex with transcranial direct current stimulation for 30 minutes
DLPFC stimulation
stimulating dorsolateral prefrontal cortex with transcranial direct current stimulation for 30 minutes
aphasia therapy
aphasia therapy for 30 minutes during transcranial direct current stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients diagnoses as post stroke aphasia
Exclusion Criteria
* patients with metal implants
* history of epilepsy
* pregnancy
* skin defect at the site of electrode attachment
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-08-124-B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.